Unlabelled: A sense of humor and an ability to laugh reduces stress, enhances hope, relieves tension, and stimulates the immune system. This study explored the role of humour on oral health status and behaviors. The factor structure and the construct validity of the Romanian version of the Multidimensional Sense of Humour Scale (MSHS) was also assessed.
Material And Methods: The present study sample consisted of 213 first year dental students. The questionnaire included information about socio-demographic factors, behavioral variables and self-reported oral health status. Sense of humour was assessed using the Multidimensional Sense of Humour Scale (MSHS) (Thorson and Powell, 1993).
Results: There was no significant gender difference with regard to total MSHS scale of humour; however, a detailed analysis of the factors and items reveals some differences in constructions of sense of humor between males and females. We have compared the highest and the lowest 30% of individuals with respect to their MSHS humour scores, in order to test the hypothesis that persons in high humour groups would report higher levels of good health than those in low humour groups. It was revealed that four of the dependent variables, oral health status, gingival health status, toothbrushing frequency and dental visit frequency differed significantly among the two groups. It was also shown that participants who flossed their teeth or used mouthwash once a month presented significant lower values of humour thon those who used everyday dental floss or oral mouthrinses. The independent variables (demographic variables [age, gender, tobacco usage] and humour) were regressed on each of the dependent oral health status and behaviour scales. Although the multiple regression analysis on gingival status was non-significant overall, humour contributed a small, but significant 1.51% of the predictive variance, P < 0.05.
Conclusions: Further research is required in order to gain a better understanding of the concept of humour and its uses in healthcare.
Download full-text PDF |
Source |
---|
Br J Dermatol
January 2025
Centre of Evidence Based Dermatology, School of Medicine, Faculty of Medicine & Health Sciences, University of Nottingham, UK.
Background: Randomised controlled trials (RCTs) evaluating new systemic treatments for atopic dermatitis (AD) have increased dramatically over the last decade. These trials often incorporate topical therapies either as permitted concomitant or rescue treatments. Differential use of these topicals post-randomisation introduces potential bias as they may nullify or exaggerate treatment responses.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute Landmark Center, Boston, Massachusetts.
Psychol Bull
January 2025
Department of Kinesiology, University of North Carolina at Greensboro.
This meta-review provides the first meta-analytic evidence from published meta-analyses examining the effectiveness of acute exercise interventions on cognitive function. A multilevel meta-analysis with a random-effects model and tests of moderators were performed in R. Thirty systematic reviews with meta-analyses (383 unique studies with 18,347 participants) were identified.
View Article and Find Full Text PDFAIDS Behav
January 2025
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Support for people living with HIV (PLHIV) as they disclose their HIV status can impact continuity of HIV treatment and adherence to antiretrovirals. In the presence of multi-level adversities, resilience among PLHIV can promote health-seeking behaviors and better health outcomes. However, few studies have examined how disclosure experience and resilience work together to impact HIV treatment outcomes among PLHIV.
View Article and Find Full Text PDFAdv Biotechnol (Singap)
June 2024
MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, 510275, China.
Autosomal dominant polycystic kidney disease (ADPKD) is a dominant genetic disorder caused primarily by mutations in the PKD1 gene, resulting in the formation of numerous cysts and eventually kidney failure. However, there are currently no gene therapy studies aimed at correcting PKD1 gene mutations. In this study, we identified two mutation sites associated with ADPKD, c.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!